ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 980 filers reported holding ASTRAZENECA PLC in Q1 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $18,222,204 | +15.6% | 233,648 | +0.4% | 0.01% | +9.1% |
Q1 2024 | $15,767,968 | -0.1% | 232,738 | -0.7% | 0.01% | -8.3% |
Q4 2023 | $15,782,850 | +0.8% | 234,341 | +1.4% | 0.01% | -7.7% |
Q3 2023 | $15,651,146 | -15.3% | 231,116 | -10.5% | 0.01% | -18.8% |
Q2 2023 | $18,486,727 | +3.6% | 258,303 | +0.5% | 0.02% | 0.0% |
Q1 2023 | $17,841,450 | +2.6% | 257,044 | +0.2% | 0.02% | -5.9% |
Q4 2022 | $17,395,066 | +21.1% | 256,564 | -2.1% | 0.02% | +13.3% |
Q3 2022 | $14,368,000 | -9.8% | 262,008 | +8.6% | 0.02% | -6.2% |
Q2 2022 | $15,933,000 | -16.6% | 241,161 | -16.3% | 0.02% | -5.9% |
Q1 2022 | $19,115,000 | +0.7% | 288,151 | -11.6% | 0.02% | +6.2% |
Q4 2021 | $18,981,000 | -5.2% | 325,864 | -2.3% | 0.02% | -15.8% |
Q3 2021 | $20,024,000 | +9.9% | 333,387 | +9.6% | 0.02% | +11.8% |
Q2 2021 | $18,222,000 | +59.3% | 304,194 | +32.2% | 0.02% | +54.5% |
Q1 2021 | $11,442,000 | -17.2% | 230,117 | -16.8% | 0.01% | -21.4% |
Q4 2020 | $13,827,000 | -10.3% | 276,587 | -1.7% | 0.01% | -26.3% |
Q3 2020 | $15,415,000 | +13.7% | 281,297 | +9.7% | 0.02% | +5.6% |
Q2 2020 | $13,561,000 | +4.7% | 256,383 | -11.6% | 0.02% | +12.5% |
Q1 2020 | $12,950,000 | -16.9% | 289,957 | -7.3% | 0.02% | +6.7% |
Q4 2019 | $15,587,000 | +10.8% | 312,643 | -0.9% | 0.02% | +7.1% |
Q3 2019 | $14,062,000 | +8.2% | 315,510 | +0.2% | 0.01% | +7.7% |
Q2 2019 | $12,998,000 | -0.5% | 314,925 | -2.5% | 0.01% | 0.0% |
Q1 2019 | $13,064,000 | -7.2% | 323,117 | -12.8% | 0.01% | -18.8% |
Q4 2018 | $14,071,000 | -15.0% | 370,489 | -11.4% | 0.02% | 0.0% |
Q3 2018 | $16,546,000 | +3.0% | 418,153 | -8.6% | 0.02% | 0.0% |
Q2 2018 | $16,070,000 | -2.5% | 457,716 | -2.9% | 0.02% | 0.0% |
Q1 2018 | $16,483,000 | +2.9% | 471,373 | +2.1% | 0.02% | 0.0% |
Q4 2017 | $16,016,000 | +99.2% | 461,548 | +94.5% | 0.02% | +100.0% |
Q3 2017 | $8,041,000 | +6.6% | 237,305 | +7.2% | 0.01% | 0.0% |
Q2 2017 | $7,546,000 | +18.3% | 221,371 | +8.1% | 0.01% | +14.3% |
Q1 2017 | $6,379,000 | +56.7% | 204,823 | +37.5% | 0.01% | +40.0% |
Q4 2016 | $4,071,000 | -16.5% | 148,993 | +0.4% | 0.01% | -16.7% |
Q3 2016 | $4,877,000 | +86.1% | 148,451 | +71.1% | 0.01% | +100.0% |
Q2 2016 | $2,620,000 | +10.8% | 86,754 | +3.4% | 0.00% | 0.0% |
Q1 2016 | $2,364,000 | -17.0% | 83,930 | -0.0% | 0.00% | 0.0% |
Q4 2015 | $2,848,000 | -62.3% | 83,942 | -64.6% | 0.00% | -66.7% |
Q3 2015 | $7,546,000 | +38.3% | 237,164 | +176.8% | 0.01% | +50.0% |
Q2 2015 | $5,458,000 | +14.9% | 85,680 | +23.4% | 0.01% | +20.0% |
Q1 2015 | $4,752,000 | +8.8% | 69,435 | +11.9% | 0.01% | 0.0% |
Q4 2014 | $4,367,000 | +5.8% | 62,044 | +7.3% | 0.01% | 0.0% |
Q3 2014 | $4,128,000 | -2.2% | 57,797 | +1.7% | 0.01% | 0.0% |
Q2 2014 | $4,223,000 | +9.9% | 56,839 | -4.1% | 0.01% | 0.0% |
Q1 2014 | $3,844,000 | +14.6% | 59,270 | +5.0% | 0.01% | +25.0% |
Q4 2013 | $3,353,000 | -1.7% | 56,460 | -14.0% | 0.00% | -20.0% |
Q3 2013 | $3,411,000 | +15.0% | 65,637 | +4.7% | 0.01% | +25.0% |
Q2 2013 | $2,967,000 | – | 62,714 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |